Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 22 2026
0mins
Should l Buy CROX?
Source: Benzinga
- Qiagen Rating Change: Deutsche Bank analyst Jan Koch downgraded Qiagen N.V. (NYSE:QGEN) from Buy to Hold while raising the price target from $52 to $54, indicating a cautious outlook on the company's future growth prospects.
- Legend Biotech Downgrade: TD Cowen analyst Yaron Werber downgraded Legend Biotech Corp (NASDAQ:LEGN) from Buy to Hold and significantly cut the price target to $21, reflecting concerns about its market performance, even as the stock closed at $20.76 on Wednesday.
- Crocs Rating Adjustment: Keybanc analyst Ashley Owens downgraded Crocs Inc (NASDAQ:CROX) from Overweight to Sector Weight, suggesting diminished confidence in the brand's future growth potential, with shares closing at $85.27 on Wednesday.
- Zoetis Rating Change: Piper Sandler analyst David Westenberg downgraded Zoetis Inc (NYSE:ZTS) from Overweight to Neutral and lowered the price target from $190 to $135, reflecting concerns about its profitability, despite the stock closing at $125.08 on Wednesday.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CROX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CROX
Wall Street analysts forecast CROX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CROX is 90.38 USD with a low forecast of 75.00 USD and a high forecast of 112.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
3 Buy
7 Hold
0 Sell
Moderate Buy
Current: 84.490
Low
75.00
Averages
90.38
High
112.00
Current: 84.490
Low
75.00
Averages
90.38
High
112.00
About CROX
Crocs, Inc. is engaged in the design, development, worldwide marketing, distribution, and sale of casual lifestyle footwear and accessories for all. The Company's brands include Crocs and HEYDUDE. The Crocs Brand's collection contains Croslite material, a proprietary, molded footwear technology. It also uses Croslite material formulations in connection with material technologies used in its visible comfort collections, such as its LiteRide and Free Feel Technology products. The HEYDUDE Brand offers shoes with an iconic and versatile loafer silhouette with many wearing occasions that focus on casualization, comfort-led functionality and personalization. It sells its products in more than 80 countries, through wholesale and direct-to-consumer channels. Its wholesale channel includes domestic and international multi-brand retailers, e-tailers and others. Its direct-to-consumer channel includes Company-operated retail stores, Company-operated e-commerce sites and third-party marketplaces.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AppLovin Shares Rise After Securing Major Clients, According to Analyst.
- AppLovin's Current Status: AppLovin has experienced a decline in performance since the beginning of the year.
- Potential for Recovery: Analysts from Needham & Company suggest that successes in the company's new e-commerce segment could positively impact its stock.
See More
Crocs, Inc. (CROX) Stock Rises to $86.72 Despite Keybanc Downgrade
- Rating Downgrade Impact: Keybanc downgraded Crocs to Sector Weight, with analyst Ashley Owens noting that despite pressures from promotional pullbacks and tighter wholesale receipts in North America, the stock is rebounding, indicating cautious optimism in the market about the company's future.
- Consumer Demand Challenges: Owens highlighted that U.S. demand remains weak, with a more selective consumer, particularly as competition intensifies in the sub-$100 athletic brand category, impacting Crocs' market performance.
- International Market Outlook: While the international market could still be a bright spot, visibility remains limited due to ongoing wholesale caution and tariff headwinds, which may affect overall performance.
- Stock Price Volatility: Despite the downgrade, Crocs shares rose 1.70% to $86.72 on Thursday, reflecting market recognition of the company's valuation, although there are limited catalysts in the near term.
See More
Crocs Inc (CROX) Downgraded to Sector Weight, Revenue Estimates Cut to $3.98 Billion
- Rating Downgrade: KeyBanc Capital Markets analyst Ashley Owens downgraded Crocs from Overweight to Sector Weight, reflecting challenges from declining U.S. demand and increased consumer selectivity.
- Revenue Forecast Cut: The analyst lowered the full-year revenue estimate for 2026 from $4.04 billion to $3.98 billion, indicating that this trend could weigh on the company's near-term results, although gross margins may benefit.
- International Market Potential: While the international market could remain a bright spot and provide long-term growth opportunities, visibility remains limited due to ongoing wholesale caution, tariff headwinds, and continued pressure from HEYDUDE's channel cleanup.
- Market Reaction: At the time of the report, Crocs shares rose by 0.33% to $85.55, reflecting a cautious market sentiment as investors await clearer signs of stabilization and sustained traction from product initiatives.
See More
Crocs, Inc. to Host Q4 2025 Earnings Call on February 12, 2026
- Earnings Call Announcement: Crocs, Inc. will host a conference call on February 12, 2026, at 8:30 AM ET to discuss its fourth quarter and full year results ending December 31, 2025, aiming to provide investors with the latest financial insights to enhance transparency.
- Webcast Availability: The conference call will be available via live webcast on Crocs' website, with a replay accessible until February 12, 2027, ensuring that investors who cannot attend live can still access key information, thereby improving communication efficiency with stakeholders.
- Company Overview: Headquartered in Broomfield, Colorado, Crocs, Inc. is a global leader in innovative casual footwear, with products sold in over 80 countries through wholesale and direct-to-consumer channels, demonstrating its extensive market reach and operational capabilities.
- Brand Diversity: The company's brands include Crocs and HEYDUDE, combining comfort and style to meet diverse consumer needs, further solidifying its leadership position in the casual footwear market.
See More
Crocs, Inc. to Host Q4 2025 Earnings Call on February 12, 2026
- Earnings Call Announcement: Crocs, Inc. will host a conference call on February 12, 2026, at 8:30 AM ET to discuss its Q4 and full-year results for the period ending December 31, 2025, which is expected to provide investors with crucial financial insights and future outlook.
- Webcast Availability: The conference call will be available via live webcast on Crocs' Investor Relations website, with registration required for details, and the replay will be accessible until February 12, 2027, ensuring that investors unable to attend live can still access the information.
- Company Overview: Headquartered in Broomfield, Colorado, Crocs, Inc. is a global leader in innovative casual footwear, with products sold in over 80 countries through wholesale and direct-to-consumer channels, showcasing its strong market presence.
- Brand Diversity: Crocs' brands include Crocs and HEYDUDE, focusing on combining comfort and style to meet consumer demands, further solidifying its leadership position in the casual footwear market.
See More
Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
- Qiagen Rating Change: Deutsche Bank analyst Jan Koch downgraded Qiagen N.V. (NYSE:QGEN) from Buy to Hold while raising the price target from $52 to $54, indicating a cautious outlook on the company's future growth prospects.
- Legend Biotech Downgrade: TD Cowen analyst Yaron Werber downgraded Legend Biotech Corp (NASDAQ:LEGN) from Buy to Hold and significantly cut the price target to $21, reflecting concerns about its market performance, even as the stock closed at $20.76 on Wednesday.
- Crocs Rating Adjustment: Keybanc analyst Ashley Owens downgraded Crocs Inc (NASDAQ:CROX) from Overweight to Sector Weight, suggesting diminished confidence in the brand's future growth potential, with shares closing at $85.27 on Wednesday.
- Zoetis Rating Change: Piper Sandler analyst David Westenberg downgraded Zoetis Inc (NYSE:ZTS) from Overweight to Neutral and lowered the price target from $190 to $135, reflecting concerns about its profitability, despite the stock closing at $125.08 on Wednesday.
See More
AppLovin Shares Rise After Securing Major Clients, According to Analyst.
- AppLovin's Current Status: AppLovin has experienced a decline in performance since the beginning of the year.
- Potential for Recovery: Analysts from Needham & Company suggest that successes in the company's new e-commerce segment could positively impact its stock.
See More
Crocs, Inc. (CROX) Stock Rises to $86.72 Despite Keybanc Downgrade
- Rating Downgrade Impact: Keybanc downgraded Crocs to Sector Weight, with analyst Ashley Owens noting that despite pressures from promotional pullbacks and tighter wholesale receipts in North America, the stock is rebounding, indicating cautious optimism in the market about the company's future.
- Consumer Demand Challenges: Owens highlighted that U.S. demand remains weak, with a more selective consumer, particularly as competition intensifies in the sub-$100 athletic brand category, impacting Crocs' market performance.
- International Market Outlook: While the international market could still be a bright spot, visibility remains limited due to ongoing wholesale caution and tariff headwinds, which may affect overall performance.
- Stock Price Volatility: Despite the downgrade, Crocs shares rose 1.70% to $86.72 on Thursday, reflecting market recognition of the company's valuation, although there are limited catalysts in the near term.
See More
Crocs Inc (CROX) Downgraded to Sector Weight, Revenue Estimates Cut to $3.98 Billion
- Rating Downgrade: KeyBanc Capital Markets analyst Ashley Owens downgraded Crocs from Overweight to Sector Weight, reflecting challenges from declining U.S. demand and increased consumer selectivity.
- Revenue Forecast Cut: The analyst lowered the full-year revenue estimate for 2026 from $4.04 billion to $3.98 billion, indicating that this trend could weigh on the company's near-term results, although gross margins may benefit.
- International Market Potential: While the international market could remain a bright spot and provide long-term growth opportunities, visibility remains limited due to ongoing wholesale caution, tariff headwinds, and continued pressure from HEYDUDE's channel cleanup.
- Market Reaction: At the time of the report, Crocs shares rose by 0.33% to $85.55, reflecting a cautious market sentiment as investors await clearer signs of stabilization and sustained traction from product initiatives.
See More
Crocs, Inc. to Host Q4 2025 Earnings Call on February 12, 2026
- Earnings Call Announcement: Crocs, Inc. will host a conference call on February 12, 2026, at 8:30 AM ET to discuss its fourth quarter and full year results ending December 31, 2025, aiming to provide investors with the latest financial insights to enhance transparency.
- Webcast Availability: The conference call will be available via live webcast on Crocs' website, with a replay accessible until February 12, 2027, ensuring that investors who cannot attend live can still access key information, thereby improving communication efficiency with stakeholders.
- Company Overview: Headquartered in Broomfield, Colorado, Crocs, Inc. is a global leader in innovative casual footwear, with products sold in over 80 countries through wholesale and direct-to-consumer channels, demonstrating its extensive market reach and operational capabilities.
- Brand Diversity: The company's brands include Crocs and HEYDUDE, combining comfort and style to meet diverse consumer needs, further solidifying its leadership position in the casual footwear market.
See More
Crocs, Inc. to Host Q4 2025 Earnings Call on February 12, 2026
- Earnings Call Announcement: Crocs, Inc. will host a conference call on February 12, 2026, at 8:30 AM ET to discuss its Q4 and full-year results for the period ending December 31, 2025, which is expected to provide investors with crucial financial insights and future outlook.
- Webcast Availability: The conference call will be available via live webcast on Crocs' Investor Relations website, with registration required for details, and the replay will be accessible until February 12, 2027, ensuring that investors unable to attend live can still access the information.
- Company Overview: Headquartered in Broomfield, Colorado, Crocs, Inc. is a global leader in innovative casual footwear, with products sold in over 80 countries through wholesale and direct-to-consumer channels, showcasing its strong market presence.
- Brand Diversity: Crocs' brands include Crocs and HEYDUDE, focusing on combining comfort and style to meet consumer demands, further solidifying its leadership position in the casual footwear market.
See More
Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
- Qiagen Rating Change: Deutsche Bank analyst Jan Koch downgraded Qiagen N.V. (NYSE:QGEN) from Buy to Hold while raising the price target from $52 to $54, indicating a cautious outlook on the company's future growth prospects.
- Legend Biotech Downgrade: TD Cowen analyst Yaron Werber downgraded Legend Biotech Corp (NASDAQ:LEGN) from Buy to Hold and significantly cut the price target to $21, reflecting concerns about its market performance, even as the stock closed at $20.76 on Wednesday.
- Crocs Rating Adjustment: Keybanc analyst Ashley Owens downgraded Crocs Inc (NASDAQ:CROX) from Overweight to Sector Weight, suggesting diminished confidence in the brand's future growth potential, with shares closing at $85.27 on Wednesday.
- Zoetis Rating Change: Piper Sandler analyst David Westenberg downgraded Zoetis Inc (NYSE:ZTS) from Overweight to Neutral and lowered the price target from $190 to $135, reflecting concerns about its profitability, despite the stock closing at $125.08 on Wednesday.
See More
